Discover 3,557 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,557
A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
for
Glycogen Storage Disease Type Ia
Location: Orange CA, Houston TX, Farmington CT
Sponsor: Beam Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06735755
Phase1, Phase2, Recruiting
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
for
Gastric Cancer, Gastroesophageal Junction Cancer,
Location: Orange CA, Palo Alto CA, Santa Rosa CA, Houston TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06219941
Phase2, Recruiting
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
for
Biliary Tract Cancer
Location: Fullerton CA, Los Angeles CA, La Jolla CA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06467357
Phase3, Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for
Non-Small Cell Lung Cancer
Location: Orange CA, Anaheim CA, Cerritos CA, Torrance CA,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT06767514
Phase3, Recruiting
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Orange CA, Bellflower CA, Riverside CA, Glendale CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07573176
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
for
Schizophrenia
Location: Orange CA, Garden Grove CA, Cerritos CA, Bellflower CA,
Sponsor: MapLight Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07459647
Phase2, Recruiting
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
for
Bipolar I Disorder
Location: Orange CA, Garden Grove CA, Bellflower CA, Torrance CA,
Sponsor: LB Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07494305
Phase2, Recruiting
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
for
Biliary Tract Cancer
Location: Orange CA, Duarte CA, Los Angeles CA, Phoenix AZ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07221253
Phase3, Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Location: Orange CA, Duarte CA, Scottsdale AZ, San Antonio TX,
Sponsor: Plexium, Inc.
Sex: All
Age: 18+
Code: NCT07284186
Phase1, Recruiting
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Location: Orange CA, San Francisco CA, Vancouver, Mansfield TX,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07088926
Phase2, Recruiting
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: Orange CA, Fountain Valley CA, Irvine CA,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase3, Recruiting
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Orange CA, Toronto, Oceanside CA, New Haven CT,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT07196501
Phase3, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Orange CA, Westminster CA, Mission Viejo CA,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase3, Recruiting
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor